Arcellx, Inc. (ACLX)

NASDAQ: ACLX · Real-Time Price · USD

70.20

+1.70 (2.48%)

At close: Feb 17, 2026, 4:00 PM EST

68.00

-2.20 (-3.13%)

After-hours: Feb 17, 2026, 7:21 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cell Therapies	107.94M
Cell Therapies Growth	-2.16%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	107.94M
United States Growth	-2.16%